WEDNESDAY, June 2, 2021 — If your child has both allergies and asthma, it’s imperative to treat their allergies to prevent asthma from worsening as they spend more time outdoors, an expert says. “It’s a time when after a winter when we’re all cooped up inside kids want to go out and play, but the… Read More »
FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, June 1, 2021 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved Lybalvi (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with… Read More »
Delayed HIV treatment initiation, use of protease inhibitors for more than a year, tobacco use and sleep apnoea increase the odds of erectile dysfunction among cisgender men living with HIV, according to the findings of the US Military HIV Natural History Study (NHS), published in HIV Medicine. Although HIV is associated with an increased risk… Read More »
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult… Read More »
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »
Scott Ostrom, a participant in the trial, has suffered from P.T.S.D. since returning from Iraq in 2007. Now, he no longer has nightmares. “Literally, I’m a different person,” he said.Credit…Elliot Ross for The New York Times SectionsSkip to contentSkip to site index A Psychedelic Drug Passes a Big Test for PTSD Treatment A new study… Read More »